E-LIB Suche - Ergebnisse für: Cork, M. A

1

Long-term laboratory safety of dupilumab in patients aged 6..:

Crépy, M.N. ; Siegfried, E.C. ; Cork, M.J....
Revue Française d'Allergologie. 64 (2024) - p. 104044 , 2024

Link: https://doi.org/10.1016/..

2

280 Children with atopic dermatitis respond more rapidly to..:

Berdyshev, E. ; Goleva, E. ; Danby, S....
Journal of Investigative Dermatology. 144 (2024) 8 - p. S48 , 2024

Link: https://doi.org/10.1016/..

3

Dupilumab treatment in children aged 6–11 years with severe..:

Cork, M.J. ; Wollenberg, A. ; Siegfried, E.C....
Revue Française d'Allergologie. 63 (2023) 3 - p. 103436 , 2023

Link: https://doi.org/10.1016/..

4

Dupilumab treatment reduces total IgE levels in patients 6 ..:

Siegfried, E.C. ; Cork, M.J. ; Boguniewicz, M....
Revue Française d'Allergologie. 63 (2023) 3 - p. 103434 , 2023

Link: https://doi.org/10.1016/..

5

Efficacy and safety of dupilumab in children aged 6–11 year..:

Cork, M.J. ; Guttman-Yassky, E. ; Simpson, E.L....
Revue Française d'Allergologie. 62 (2022) 3 - p. 321 , 2022

Link: https://doi.org/10.1016/..

6

Risk of severe allergic reactions to COVID‐19 vaccines amon..:

Ring, J. ; Worm, M. ; Wollenberg, A....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 6 - p. , 2021

Link: https://doi.org/10.1111/..

7

Impact of oral abrocitinib on signs, symptoms and quality o..:

Cork, M.J. ; McMichael, A. ; Teng, J....
Journal of the European Academy of Dermatology and Venereology. 36 (2021) 3 - p. 422-433 , 2021

Link: https://doi.org/10.1111/..

8

European Task Force on Atopic Dermatitis: position on vacci..:

Thyssen, J.P. ; Vestergaard, C. ; Barbarot, S....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 5 - p. , 2021

Link: https://doi.org/10.1111/..

9

Randomized controlled pilot trial with ion‐exchange water s..:

Jabbar‐Lopez, Z. K. ; Ezzamouri, B. ; Briley, A....
Clinical & Experimental Allergy. 52 (2021) 3 - p. 405-415 , 2021

Link: https://doi.org/10.1111/..

10

A study of dupilumab in the treatment of adolescents with e..:

Cork, M.J. ; Thaçi, D. ; Eichenfield, L.F....
British Journal of Dermatology. 182 (2020) 1 - p. e30-e30 , 2020

Link: https://doi.org/10.1111/..

11

A study of gene mutations and how they relate to the differ..:

Simpson, J.K. ; Martinez‐Queipo, M. ; Onoufriadis, A....
British Journal of Dermatology. 182 (2020) 3 - p. , 2020

Link: https://doi.org/10.1111/..

12

Dupilumab provides favourable long‐term safety and efficacy..:

Cork, M.J. ; Thaçi, D. ; Eichenfield, L.F....
British Journal of Dermatology. 184 (2020) 5 - p. 857-870 , 2020

Link: https://doi.org/10.1111/..

13

Tralokinumab for moderate‐to‐severe atopic dermatitis: resu..:

Wollenberg, A. ; Blauvelt, A. ; Guttman‐Yassky, E....
British Journal of Dermatology. 184 (2020) 3 - p. 437-449 , 2020

Link: https://doi.org/10.1111/..

14

一项关于基因突变及其与不同鱼鳞病类型相关性的研究:

Simpson, J.K. ; Martinez‐Queipo, M. ; Onoufriadis, A....
British Journal of Dermatology. 182 (2020) 3 - p. , 2020

Link: https://doi.org/10.1111/..

15

A phase 2, open‐label study of single‐dose dupilumab in chi..:

Paller, A.S. ; Siegfried, E.C. ; Simpson, E.L....
Journal of the European Academy of Dermatology and Venereology. 35 (2020) 2 - p. 464-475 , 2020

Link: https://doi.org/10.1111/..